This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1999-2000.
Location History:
- Welwyn Garden City, GB (1999)
- Welwyn Garden, GB (2000)
Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Bradley Stuart Sherborne
Introduction
Bradley Stuart Sherborne is a notable inventor based in Welwyn Garden City, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target viral infections. With a total of 2 patents to his name, Sherborne's work has the potential to impact the treatment of herpes simplex virus infections.
Latest Patents
Sherborne's latest patents include innovative compounds that are designed to inhibit the herpes simplex virus thymidine kinase. The first patent focuses on xanthene and acridine derivatives, which are new and known tricyclic dione derivatives. These compounds are crucial in the treatment and prophylaxis of infections caused by the herpes simplex virus. The second patent also involves acridine derivatives, which share a similar structural framework and therapeutic application.
Career Highlights
Bradley Stuart Sherborne is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to collaborate with other talented professionals in the field, enhancing the development of innovative treatments.
Collaborations
Some of Sherborne's notable coworkers include Joseph A Martin and Gareth Mark Taylor. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical sector.
Conclusion
In summary, Bradley Stuart Sherborne is a distinguished inventor whose work in developing antiviral compounds showcases his commitment to improving healthcare. His contributions are vital in the ongoing fight against viral infections, particularly those caused by the herpes simplex virus.